Nuveen Investments Links
Login
Nuveen Investments
Print
Page
Email
Page
Literature
To order literature, put the amount requested in the order box next to the corresponding document and click “submit” at the bottom of the page. You should expect to receive your order with in five business days. If a document does not have an order box next to it, it is not orderable at this time.
Annual Reports
995 documents.
Document
Order
Role
California Insured 371 Annual Report 2008
Investor
California Insured 370 Annual Report 2008
Investor
California Insured 369 Annual Report 2008
Investor
California Insured 368 Annual Report 2008
Investor
California Insured 367 Annual Report 2008
Investor
1
2
3
4
5
6
7
8
9
10
...
Brochures
1 document.
Document
Order
Role
DP Distribution Instructions
Investor
1
Fact Sheets and Presentations
No documents to display.
Highlights
1053 documents.
Document
Order
Role
New York Insured 332 Highlight
Investor
National Insured 469 Highlight
Investor
Ohio Insured 200 Highlight
Investor
New Jersey Insured 283 Highlight
Investor
Florida Insured 317 Highlight
Investor
1
2
3
4
5
6
7
8
9
10
...
Multi Media Show
No documents to display.
Prospectus - Defined Portfolio
928 documents.
Document
Order
Role
Nuveen Tax-Free Unit Trusts - Prospectus Part B dated April 12, 2001
Investor
Series 1285 Prospectus - NY Ins 332, NA Ins 469
Investor
Series 1284 Prospectus
Investor
Series 1283 Prospectus
Investor
Series 1282 Prospectus
Investor
1
2
3
4
5
6
7
8
9
10
...
An investor should carefully consider fund objectives, risks, charges and expenses before investing. For this and more information on Nuveen funds, please view a
prospectus
. Please read it carefully before you invest or send money.
See our
privacy policy
,
important legal information
and our
business continuity plan summary
. The content of this site, including but not limited to the text and images herein and their arrangement are
Copyright
by Nuveen Investments. 333 W. Wacker Dr., Chicago, IL 60606. Funds distributed by Nuveen Investments, LLC. Investor line: 1-800-257-8787.
The information on this web site is intended for U.S. residents only. The information provided does not constitute a solicitation of an offer to buy, or an offer to sell securities in any jurisdiction to any person to whom it is not lawful to make such an offer.
